These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 10063483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of social phobia with antidepressants.
    Schneier FR.
    J Clin Psychiatry; 2001; 62 Suppl 1():43-8; discussion 49. PubMed ID: 11206033
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
    Nair NP, Ahmed SK, Kin NM, West TE.
    Acta Psychiatr Scand Suppl; 1995; 386():28-35. PubMed ID: 7717092
    [Abstract] [Full Text] [Related]

  • 10. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ, Aarons SF, Frances AJ, Brown RD.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversible monoamine oxidase-A inhibitors in panic disorder.
    Bakish D, Saxena BM, Bowen R, D'Souza J.
    Clin Neuropharmacol; 1993 Jul; 16 Suppl 2():S77-82. PubMed ID: 8313401
    [Abstract] [Full Text] [Related]

  • 15. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G, Finberg JP, Youdim MB.
    Clin Neuropharmacol; 1993 Jul; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB.
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [Abstract] [Full Text] [Related]

  • 18. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 May; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 19. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 20. MAOIs in the contemporary treatment of depression.
    Thase ME, Trivedi MH, Rush AJ.
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.